Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX5A gene.
Features include always present findings: Increased circulating lactate concentration, High blood pressure in lung arteries (pulmonary arterial hypertension), and Elevated circulating hepatic transaminase concentration; and common findings: Lethargy, Wide anterior fontanel, Deeply set eye, and Long eyelashes and others. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 3 |
COX5A encodes cytochrome c oxidase subunit 5A (150 aa). Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. Highest expression in Heart Left Ventricle (421.1 TPM) and Muscle Skeletal (389.6 TPM).
Mitochondrial complex IV deficiency, nuclear type 20 is associated with mutations in the COX5A gene on chromosome 15.
The COX5A protein participates in TIMM21 carries COX4, COX5A, COX6C to MT-CO1:MITRAC, TIMM23 SORT inserts proteins into inner membrane, and AFG3L2 degrades mitochondrial inner membrane proteins pathways.
COX5A is classified as a druggable target (Enzyme and Transporter categories) with score 0.0.
Genetic testing for COX5A is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 8 common features.
No clinical trials have been registered for mitochondrial complex IV deficiency, nuclear type 20.
4 publications have been identified in PubMed for mitochondrial complex IV deficiency, nuclear type 20. Research spans Basic Science / Preclinical (75%) and Review / Meta-Analysis (25%).
Čunátová K (2026). [PMID: 41419202](https://pubmed.ncbi.nlm.nih.gov/41419202/). *J Biol Chem*. [Basic Science / Preclinical]
He X (2026). [PMID: 41580081](https://pubmed.ncbi.nlm.nih.gov/41580081/). *J Biol Chem*. [Basic Science / Preclinical]
Zhang L (2025). [PMID: 39716856](https://pubmed.ncbi.nlm.nih.gov/39716856/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Pham L (2024). [PMID: 39566165](https://pubmed.ncbi.nlm.nih.gov/39566165/). *Redox Biol*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Heart and blood vessels | 2 | Enlarged heart (cardiomegaly), High blood pressure in lung arteries (pulmonary arterial hypertension) |
Digestive system | 2 | Enlarged liver (hepatomegaly), Elevated circulating hepatic transaminase concentration |
Growth and development | 1 | Failure to thrive in infancy |
Muscles | 1 | Low muscle tone (hypotonia) |
Lungs and breathing | 1 | High blood pressure in lung arteries (pulmonary arterial hypertension) |